2019 UEM Edgenta Annual Report

208 209 UEM EDGENTA AT A GLANCE MESSAGE FROM OUR LEADERSHIP STRATEGIC FOCUS OPERATIONAL REVIEW SUSTAINABILITY EFFORTS CORPORATE GOVERNANCE INTRODUCTION FINANCIAL REVIEW ADDITIONAL INFORMATION Notes to the Financial Statements For the year ended 31 December 2019 Notes to the Financial Statements For the year ended 31 December 2019 UEM Edgenta Berhad Annual Report 2019 17. INVESTMENT IN SUBSIDIARIES (CONT’D.) Summarised financial information (cont’d.) (iii) Summarised statements of cash flows Rimbunan Melati UEMS Group EGT Total 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 Net cash (used in)/generated from operating activities (4,462) (223) 51,046 30,460 7,410 20,830 53,994 51,067 Net cash generated from/(used in) investing activities 11,150 (10,000) (14,680) (4,366) 407 311 (3,123) (14,055) Net cash (used in)/generated from financing activities (7,500) - (21,701) (29,861) 4,377 (3,227) (24,824) (33,088) Net (decrease)/ increase in cash and cash equivalents (812) (10,223) 14,665 (3,767) 12,194 17,914 26,047 3,924 Net foreign exchange differences - - (21) (228) (214) 37 (235) (191) Cash and cash equivalents at beginning of the year 12,589 22,812 100,218 104,213 54,202 36,251 167,009 163,276 Cash and cash equivalents at end of the year 11,777 12,589 114,862 100,218 66,182 54,202 192,821 167,009 18. INVESTMENT IN ASSOCIATES Group 2019 RM’000 2018 RM’000 Unquoted shares, at cost In Malaysia 6,122 6,068 Outside Malaysia 6,082 6,082 12,204 12,150 Share of post-acquisition reserves 70,587 55,485 Less: Dividend received (5,786) (6,400) 77,005 61,235 Further details of the associates are disclosed in Note 45. Summarised financial information of Faber Sindoori Management Services Private Limited (“Faber Sindoori”), Biomedix Solutions Sdn. Bhd. (“Biomedix”), One Medicare Sdn. Bhd. (“One Medicare”) and Sedafiat Sdn. Bhd. (“Sedafiat”), that are material associates of the Group are set out below. The summarised financial information represents the amounts in the MFRS financial statements of the associates and not the Group’s share of those amounts. (i) Summarised statements of financial position Faber Sindoori Biomedix One Medicare Sedafiat Total 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 Non-current assets 8,509 4,039 2,400 2,835 8,620 8,469 31,716 21,059 51,245 36,402 Current assets 65,840 53,273 38,277 31,306 74,215 65,124 59,017 76,852 237,349 226,555 Total assets 74,349 57,312 40,677 34,141 82,835 73,593 90,733 97,911 288,594 262,957 Non-current liabilities 4,213 2,499 84 541 1,416 3,164 844 2,385 6,557 8,589 Current liabilities 14,782 9,012 5,103 6,694 49,190 40,338 43,404 62,863 112,479 118,907 Total liabilities 18,995 11,511 5,187 7,235 50,606 43,502 44,248 65,248 119,036 127,496 Net assets 55,354 45,801 35,490 26,906 32,229 30,091 46,485 32,663 169,558 135,461